ASM International Q4 strong, but weak orders and cautious outlook pressure stock February 26, 2025 Comments are off
Nektar completes enrollment for alopecia study of rezpegaldesleukin February 26, 2025 Comments are off
FDA Grants Priority Review to Merck's Application for KEYTRUDA ® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinom February 25, 2025 Comments are off
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients February 25, 2025 Comments are off
Defense Trade Solutions Simplifies Export Compliance with Descartes Solution February 25, 2025 Comments are off